Posterior Vitreous Detachment Clinical Trial
Official title:
Randomized Trial of Laser Ablation for Highly Symptomatic Floaters
Vitreous floaters are tiny, cloudy, clumps of cells that appear in the otherwise clear fluid (vitreous) that fills the back 3/4 of the eye. Floaters are commonly caused by eye conditions such as posterior vitreous detachment (PVD), vitreous syneresis and asteroid hyalosis. While these symptoms are considered physiological in nature, they can be of considerable inconvenience to many patients which affect essential activities. The investigators wish to assess the safety and efficacy of floater treatment in patients with highly symptomatic floaters using an FDA approved nanosecond infrared yttrium aluminum garnet (YAG) lasers.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04727398 -
The Incidence of Complete Posterior Vitreous Degeneration After Phacoemulsification
|
N/A | |
Completed |
NCT01415037 -
Annular Array Ultrasound in Ophthalmology
|
||
Completed |
NCT00408720 -
Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies
|
N/A | |
Recruiting |
NCT04719871 -
Vitreous Detachment and Glaucoma Progression
|
||
Recruiting |
NCT02290795 -
Vitreopapillary Interface and Optic Disc Morphology
|
N/A | |
Not yet recruiting |
NCT04726267 -
Incidence of Complete Posterior Vitreous Detachment After Trabeculectomy.
|
N/A | |
Completed |
NCT02897583 -
YAG Vitreolysis for Floaters
|
N/A | |
Completed |
NCT00633854 -
High-frequency-ultrasound Annular Arrays for Ophthalmic Imaging
|
||
Terminated |
NCT02681809 -
A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR
|
Phase 2 | |
Completed |
NCT00831350 -
Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations
|
Phase 2 |